SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-10-030184
Filing Date
2010-05-21
Accepted
2010-05-21 16:25:06
Documents
10
Effectiveness Date
2010-05-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A a10-9595_11defa14a.htm DEFA14A 72993
2 GRAPHIC g959511bci001.jpg GRAPHIC 6550
3 GRAPHIC g959511bci002.jpg GRAPHIC 2387
4 GRAPHIC g959511bci003.gif GRAPHIC 3666
5 GRAPHIC g959511bci004.gif GRAPHIC 1633
6 GRAPHIC g959511bci005.jpg GRAPHIC 1652
7 GRAPHIC g959511bci006.jpg GRAPHIC 3668
8 GRAPHIC g959511bci007.jpg GRAPHIC 2580
9 GRAPHIC g959511bai001.jpg GRAPHIC 7714
10 GRAPHIC g959511bai002.jpg GRAPHIC 2162
  Complete submission text file 0001104659-10-030184.txt   119839
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14680 | Film No.: 10851380
SIC: 2836 Biological Products, (No Diagnostic Substances)